Warrant [Member]
Class of Warrant or Right [Axis]
Restricted Stock Units [Member]
Award Type [Axis]
Stock Option Plan [Member]
Stock Option Plan [Member]
Warrant [Member]
Options Granted To Consultants [Member]
Mark Baum Chief Executive Officer [Member]
Title of Individual [Axis]
Consultant [Member]
Employees - Selling, General And Administrative [Member]
Related Party [Axis]
Employees Research And Development [Member]
Directors - Selling, General And Administrative [Member]
Director - Selling And Administrative [Member]
Consultants - Selling, General And Administrative [Member]
Consultants Research And Development [Member]
2007 Incentive Stock And Awards Plan [Member]
Major Types of Debt and Equity Securities [Axis]
Range One [Member]
Exercise Price Range [Axis]
Stock Option 2 [Member]
Stock Option 3 [Member]
Stock Option 4 [Member]
Stock Option 5 [Member]
Options Granted To Employees [Member]
Tranche 1 CEO [Member]
Tranche 2 CEO [Member]
Tranche 3 CEO [Member]
Tranche 4 CEO [Member]
Tranche 5 CEO [Member]
Consultant Tranche 1 [Member]
Consultant Tranche 2 [Member]
Consultant Tranche 3 [Member]
Consultant Tranche 4 [Member]
Consultant Tranche 5 [Member]
Derma Star [Member]
April PPM [Member]
Underwriter Warrants [Member]
IR Consultant [Member]
Minimum [Member]
Range [Axis]
Maximum [Member]
Stock Option Two [Member]
Stock Option Three [Member]
Dr. Robert J. Kammer [Member]
Dr.Balbir Brar [Member]
Consultant 2 [Member]
450,000 Restricted Stock [Member]
600,000 Restricted Stock [Member]
100,000 Restricted Stock [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Tranche 1 CEO [Member]
Tranche 2 CEO [Member]
Tranche 3 CEO [Member]
Consultant Tranche 1 [Member]
Consultant Tranche 2 [Member]
Consultant Tranche 3 [Member]
Consultant Tranche 4 [Member]
Consultant Tranche 5 [Member]
IR Consultant [Member]
IR Consultant [Member]
Paul Finnegan [Member]
Subsequent Event [Member]
Subsequent Event Type [Axis]
Peter Kenny [Member]
Restricted Shares [Member]
Restricted Stock Units One [Member]
Contingencies One [Member]
Contingencies Two [Member]
Employees Selling And Marketing [Member]
Employees General And Administrative [Member]
Directors General And Administrative [Member]
Consultants Selling And Marketing [Member]
Consultants General And Administrative [Member]
Customer Relationships [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Trade Name [Member]
Non-Compete Covenant [Member]
Licensing [Member]
Pharmacy Creations, LLC [Member]
Legal Entity [Axis]
Period Ending March 31, 2016
Report Date [Axis]
Employees And Directors [Member]
Document And Entity Information
Entity Registrant Name
Entity Central Index Key
Document Type
Document Period End Date
Amendment Flag
Current Fiscal Year End Date
Entity Filer Category
Entity Common Stock, Shares Outstanding
Document Fiscal Period Focus
Document Fiscal Year Focus
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash and cash equivalents
Restricted short-term investment
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Total current assets
Intangible assets, net
Goodwill
Furniture and equipment, net
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses
Accrued payroll and related liabilities
Customer deposits
Current portion of contingent acquisition obligations
Current portion of capital lease obligation
Total current liabilities
Capital lease obligation, net of current portion
Contingent acquisition obligations, net of current portion
TOTAL LIABILITIES
Commitments and contingencies
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value, 395,000,000 shares authorized, 9,127,870 and 8,970,364 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenues:
Pharmacy sales, net
License revenues
Total revenues
Cost of pharmacy sales
Gross profit
Operating Expenses:
Selling and marketing
General and administrative
Research and development
Total operating expenses
Loss from operations
Other income (expense):
Interest expense
Interest income
Total other income, net
Net loss
Basic and diluted net loss per share of common stock
Weighted average number of shares of common stock outstanding, basic and diluted
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of furniture and equipment
Amortization of intangible assets
Stock-based compensation and payments
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Accrued payroll and related liabilities
Customer deposits
Deferred revenue
NET CASH USED IN OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of restricted short-term investments
Purchase of Pharmacy Creations, LLC, net of cash and advances
Purchases of furniture and equipment
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Cancelled common stock
Payments on capital lease obligation
Net proceeds from the exercise of warrants and stock options
Proceeds from issuance of common stock and warrants for cash, net of offering costs
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET CHANGE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of period
CASH AND CASH EQUIVALENTS, end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Reclassification of deferred offering costs in connection with equity offering
Issuance of common stock for consulting services included in accounts payable and accrued expenses
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview, Basis of Presentation and Summary of Significant Accounting Policies
Business Combinations [Abstract]
Acquisition - Pharmacy Creations, Llc
Restricted Short-Term Investment
Restricted Short-Term Investment
Inventory Disclosure [Abstract]
Inventories
Prepaid Expenses And Other Current Assets
Prepaid Expenses and Other Current Assets
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill
Debt Disclosure [Abstract]
Accounts Payable and Accrued Expenses
Debt
Equity [Abstract]
Stockholders' Equity and Stock-based Compensation
Compensation and Retirement Disclosure [Abstract]
Employee Savings Plan
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Segment Reporting [Abstract]
Segment Information
Subsequent Events [Abstract]
Subsequent Events
Accounting Policies [Abstract]
Company and Background
Basis of Presentation
Business Combinations
Research and Development
Intellectual Property
Revenue Recognition and Deferred Revenue
Cost of Sales
Income Taxes
Cash and Cash Equivalents
Concentrations of Credit Risk
Accounts Receivable
Inventories
Furniture and Equipment
Goodwill and Intangible Assets
Impairment of Long-Lived Assets
Deferred Rent
Fair Value Measurements
Stock-Based Compensation
Basic and Diluted Net Loss per Common Share
Use of Estimates
Reclassifications
Recently Adopted Accounting Pronouncements
Recently Announced Accounting Pronouncements
Schedule of Stock Based Compensation and Equity Instruments
Schedule of Basic and Diluted Earnings Per Common Share
Schedule of Acquisition Date Fair Value of Consideration
Schedule of Estimated Fair Value of Assets Acquired and Liabilities Assumed
Schedule of Result of Operation from Acquisition
Schedule of Pro Forma Financial Information
Schedule of Intangible Assets Acquisition
Schedule of Inventories
Prepaid Expenses And Other Current Assets Tables
Schedule of Prepaid Expenses and Other Current Assets
Schedule of Intangible Assets
Schedule of Amortization Expenses for Intangible Assets
Schedule of Estimated Future Amortization Expense
Schedule of Changes in Carrying Value of Goodwill
Schedule of Accounts Payable and Accrued Expenses
Schedule of Stock Option Plan Activity
Schedule of Fair Value Assumption
Schedule of Shares Outstanding and Exercisable
Schedule of Restricted Stock Units Activity
Schedule of Warrants Activity
Schedule of Warrants Outstanding and Warrants Exercisable
Schedule of Lease Equipment Under Capital Lease
Statement [Table]
Statement [Line Items]
Revenue
Guaranteed minimum royalty amount
Additional royalty payments based on percent of net sales
Deposit coverage limits by FDIC, per owner
Cash deposits in excess of FDIC limits
Accounts receivable, net of allowance for doubtful accounts
Impairment of long-lived assets
Number of common stock issued during period for contract dispute, shares
Number of common stock issued during period for contract dispute, value
Common stock equivalents, dilutive instruments
Unrecognized tax benefits
Numerator - net loss
Denominator - weighted average number of shares outstanding, basic and diluted
Net loss per share, basic and diluted
Compensation Expenses
Cash paid for business acquisition
Contingent cash payment
Expected revenue
Expected revenue date
Maximum number of common stock applied for contingent stock payment
Condition for contingent stock payment
Business acquisition, total fair value transferred
Business combination purchase price allocation for good will
Cash payment to sellers at closing
Contingent common stock issuance to the Sellers
Contingent cash consideration to the Sellers
Total acquisition date fair value
Cash and cash equivalents
Accounts receivable
Prepaid expenses and other assets
Inventory
Property and equipment
Intangible assets
Total identifiable assets acquired
Accounts payable and accrued liabilities
Other liabilities
Total liabilities assumed
Total identifiable assets less liabilities assumed
Net assets acquired
Total revenues
Operating loss
Total revenues
Net loss
Fair Value
Useful Life
Restricted Short-Term Investment Details Narrative
Certificate of deposit
Raw materials
Finished goods
Total inventories
Prepaid Expenses And Other Current Assets - Schedule Of Prepaid Expenses And Other Current Assets Details
Prepaid stock-based consulting expenses
Prepaid rent
Prepaid insurance
Other prepaid expenses and deposits
Total prepaid expenses and other current assets
Amortization periods (in years)
Cost
Accumulated amortization
Net Carrying value
Amortization of intangible assets
Remainder of 2014
2015
2016
2017
2018
Goodwill, Beginning
Goodwill
Acquisition of PC
Goodwill, Ending
Accounts payable
Other accrued expenses
Total accounts payable and accrued expenses
Line of credits borrowing limit maximum
Line of credit facility interest rate description
Borrowed term loan
Debt maturity date
Term loan interest rate description
Common stock issued shares
Common stock issued shares value
Shares issued upon exercise of stock options, shares
Shares issued upon exercise of stock options
Additional shares issued upon exercise of stock options, shares
Exercise of common stock option to purchase of common stock
Shares issued upon warrants exercise
Proceeds from warrants exercise
Common stock exercise price per share
Preferred stock, shares authorized
Preferred stock, par value
Preferred stock, shares issued
Preferred stock, shares outstanding
Maximum number of common stock issuance under the plan
stock option exercise price
Intrinsic value of stock options exercised
Contractual term of stock options granted
Stock options granted vesting terms
Percentage of forfeiture factor
Total unrecognized compensation expense related to unvested stock options granted under the Plan
Expense expected to recognize over the weighted-average remaining vesting period
Stock-based compensation
RSUs were forfeited
Intrinsic value of warrants exercised
Number of shares, Outstanding, Beginning balance
Number of shares, Options granted
Number of shares, Options exercised
Number of shares, Options cancelled/forfeit
Number of shares, Outstanding, Ending balance
Number of shares, Options exercisable
Number of shares, Options vested and expected to vest
Weighted Avg. Exercise Price, Outstanding, Beginning balance
Weighted Avg. Exercise Price, Options granted
Weighted Avg. Exercise Price, Options exercised
Weighted Avg. Exercise Price, Options cancelled/forfeit
Weighted Avg. Exercise Price, Outstanding, Ending balance
Weighted Avg. Exercise Price, Exercisable Ending Balance
Weighted Avg. Exercise Price, Vested and expected to vest - end of period
Weighted Avg. Remaining Contractual Life, Options outstanding
Weighted Avg. Remaining Contractual Life, Options exercisable
Weighted Avg. Remaining Contractual Life, Options vested and expected to vest
Aggregate Intrinsic Value, Options outstanding
Aggregate Intrinsic Value, Options exercisable
Aggregate Intrinsic Value, Options vested and expected to vest
Weighted-average fair value of options granted
Expected terms (in years)
Expected volatility, minimum
Expected volatility, maximum
Risk-free interest rate, minimum
Risk-free interest rate, maximum
Dividend yield
Range of Exercise Prices, minimum
Range of Exercise Prices, maximum
Number of Options Outstanding
Weighted Average Remaining Contractual Life in Years
Weighted Average Exercise Price
Number Exercisable
Weighted Average Exercisable Exercise Price
Number of RSUs, Outstanding, Beginning balance
Number of RSUs granted
Number of RSUs vested
Number of RSUs cancelled/forfeit
Number of RSUs, Outstanding, Ending balance
Weighted Average Grant Date Fair Value, Beginning balance
Weighted Average Grant Date Fair Value, RSUs granted
Weighted Average Grant Date Fair Value, RSUs vested
Weighted Average Grant Date Fair Value, RSUs cancelled/forfeit
Weighted Average Grant Date Fair Value, Ending balance
Number of shares, Outstanding, Beginning balance
Number of Shares Subject to Warrants Outstanding, Granted
Number of Shares Subject to Warrants Outstanding, Exercised
Number of Shares Subject to Warrants Outstanding, Expired
Number of shares, Outstanding, Ending balance
Weighted average remaining contractual life of the outstanding warrants in years
Weighted Avg. Exercise Price, Outstanding, Beginning balance
Weighted Avg. Exercise Price, Granted
Weighted Avg. Exercise Price, Exercised
Weighted Avg. Exercise Price, Expired
Weighted Avg. Exercise Price, Outstanding, Ending balance
Issue Date
Warrants Outstanding
Exercise Price
Warrants Exercisable
Expiration Date
Percentage of salary deposits in tax deferred investment account
Percentage of contributions made by the company
Contributions by the company
Leases equipment under capital lease with interest rate
Lease agreement for office space (Square feet)
Operating lease Expiry
Operating lease, monthly rental
Operating lease, rent increase percentage
Operating lease description
Royalties range percentage
Maximum aggregate value of cash fees
Remainder of 2014
2015
2016
Total minimum lease payments
Less amount representing interest
Present value of future minimum lease payments
Less current portion
Capital lease obligation, net of current portion
Percentage of sales derived from single customer
Percentage of drug and chemical purchases from three main suppliers
Equity Components [Axis]
Shares issued upon exercise of stock options
Acquisition Of Related Party Goodwill.
Additional royalty payments based on percent of net sales.
Aggregate Value Of Cash Fees
April Ppm [Member].
Business Acquisition Purchase Price Allocation Goodwill.
Common Stock Equivalents Dilutive Instruments.
Common stock exercise price per share.
Company and Background [Policy Text Block]
Consultant
Consultant Tranche 1
Consultant Tranche 2
Consultant Tranche 3
Consultant Tranche 4
Consultant Tranche 5
Consultant Tranche Five [Member]
Consultant Tranche Four [Member]
Consultant Tranche One [Member]
Consultant Tranche Three [Member]
Consultant Tranche Two [Member]
Consultant Two [Member]
Consultants General And Administrative [Member].
ConsultantsResearchAndDevelopment [Member]
Consultants Selling And Marketing [Member].
Consultants Selling General And Administrative [Member]
Contingencies One [Member].
Contingencies Two [Member].
Contingent cash consideration to the relatedparty.
Contingent common stock issuance to the Sellers.
Percentage of contributions made by the company.
Derma Star [Member].
Director Selling And Administrative [Member]
Directors General And Administrative [Member].
Directors selling general and administrative [Member]
Employees And Directors [Member]
Employees General And Administrative [Member].
EmployeesResearchAndDevelopmentMember
Employees Selling And Marketing [Member].
Employees selling general and administrative [Member]
Tranche 1 CEO
Tranche 2 CEO
Tranche 3 CEO
Tranche 4 CEO
Tranche 5 CEO
Executive Restricted Stock Units Tranche One [Member]
Executive Restricted Stock Units Tranche Three [Member]
Executive Restricted Stock Units Tranche Two [Member]
Expected revenue date.
Expected revenue.
Four Lakhs Fifty Thousand Restricted Stock [Member]
Intellectual property [policy text block]
IR Consultant
Ir Consultant One [Member].
Ir Consultant Two [Member].
Leases Equipment Under Capital Lease With Interest Rate.
Maximum deposit coverage limits.
Number Exercisable
Number Of Shares Applied For Contigent Stock Payment.
One Lakh Restricted Stock [Member]
Options granted to employees
Options exercise price.
Options granted to consultants
Other accrued expenses
Payment Of Cash To Contigent.
Percentage of drug and chemical purchases from three main suppliers.
Percentage of forfeiture factor.
Percentage of salary deposits in tax deferred investment account.
Period Ending March 31, 2016 [Member]
Peter Kenny [Member]
Pharmacy Creations Llc [Member].
Prepaid Expenses And Other Current Assets [TextBlock].
Prepaid Stock based Consulting Expenses.
Range five [member]
Range four [member].
Range one [member].
Range three [member].
Range two [member].
Recently Announced Accounting Pronouncements [PolicyTextBlock].
Reclassification Of Deferred Offering CostsIn Connectionwit Equity Offering
Restricted shares [member].
Restricted Stock Units RSU One [Member].
Royalties Range Percentage
Schedule Of Prepaid Expenses And Other Current Assets [TableTextBlock].
Schedule Of Restrited Stock Units Activity
Schedule of Result of Operation from Acquisition [Table Text Block].
Schedule Of Warrants Activity
Schedule of Warrants Outstanding And Warrants Exercisable
Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
Warrants Outstanding
Exercise Price
Vested
Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Total Intrinsic Value.
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
Weighted Average Exercisable Exercise Price
Warrants Exercisable
Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term
Share based Compensation Arrangement By Share based Payment Award Options Granted Weighted Average Remaining Contractual Term1.
Six Lakhs Restricted Stock [Member]
Number of common stock issued during period for contract dispute, shares.
Number of common stock issued during period for contract dispute, value.
Stock Issued During Period Shares Stock Options Exercised One.
Stock Issued During Period Shares Warrants Exercised.
StockOption2Member
StockOption3Member
StockOption4Member
StockOption5Member
StockOptionPlanMember
Stock Option Three [Member]
Stock Option Two [Member]
Stock Options Granted Vesting Terms Description.
2007 Incentive Stock And Awards Plan [Member]
Underwriter Warrants [Member].
Warrant
Warrants Expiration Date.
Warrants Issuance Date.
Business Acquisition Contingent Acquired Obligations Liabilities.
Exercise of common stock option to purchase of common stock.
Equity Option [Member]
WarrantActivityMember
ExecutiveRestrictedStockUnitsTrancheOneMember
ExecutiveRestrictedStockUnitsTrancheTwoMember
ExecutiveRestrictedStockUnitsTrancheThreeMember
ConsultantTrancheOneMember
ConsultantTrancheTwoMember
ConsultantTrancheThreeMember
ConsultantTrancheFourMember
ConsultantTrancheFiveMember
IrConsultantOneMember
IrConsultantTwoMember
Assets, Current
Assets
Liabilities, Current
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Revenue, Net
Health Care Organization, Medical Supplies and Drugs Expense
Gross Profit
Operating Costs and Expenses
Operating Income (Loss)
Interest Expense, Other
Other Nonoperating Expense
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Increase (Decrease) in Employee Related Liabilities
Increase (Decrease) in Customer Deposits
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Payments for Repurchase of Common Stock
Repayments of Debt and Capital Lease Obligations
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Cash, Cash Equivalents, and Short-term Investments [Text Block]
Inventory Disclosure [Text Block]
Inventory, Policy [Policy Text Block]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net
Business Acquisition, Pro Forma Revenue
Business Acquisition, Pro Forma Net Income (Loss)
Amortization of Intangible Assets
Goodwill, Other Changes
Accounts Payable and Accrued Liabilities
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
Capital Leases, Future Minimum Payments Due, Next Twelve Months
Capital Leases, Future Minimum Payments Due in Two Years
Capital Leases, Future Minimum Payments Due in Three Years
Capital Leases, Future Minimum Payments Due
Capital Leases, Future Minimum Payments, Interest Included in Payments
Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments